BDP5290 is a dual inhibitor of both Rho-associated coiled-coil containing protein kinase (ROCK) and myotonic dystrophy kinase-related Cdc42-binding protein kinase (MRCK). It has demonstrated the ability to block cancer invasion, making it a promising candidate for cancer treatment.
1817698-21-7
Post Buying Request-
-
Basic information
- Product Name: BDP5290
- Synonyms: BDP5290
- CAS NO:1817698-21-7
- Molecular Formula: C17H18ClN7O
- Molecular Weight: 371.82412
- EINECS: -0
- Product Categories: N/A
- Mol File: 1817698-21-7.mol
-
Chemical Properties
- Melting Point: N/A
- Boiling Point: 584.0±50.0 °C(Predicted)
- Flash Point: N/A
- Appearance: /
- Density: 1.56±0.1 g/cm3(Predicted)
- Refractive Index: N/A
- Storage Temp.: N/A
- Solubility: N/A
- PKA: 10.83±0.50(Predicted)
- CAS DataBase Reference: BDP5290(CAS DataBase Reference)
- NIST Chemistry Reference: BDP5290(1817698-21-7)
- EPA Substance Registry System: BDP5290(1817698-21-7)
-
Safety Data
- Hazard Codes: N/A
- Statements: N/A
- Safety Statements: N/A
- WGK Germany:
- RTECS:
- HazardClass: N/A
- PackingGroup: N/A
- Hazardous Substances Data: 1817698-21-7(Hazardous Substances Data)
1817698-21-7 Suppliers
Recommended suppliersmore
1817698-21-7 Usage
Uses
Used in Cancer Treatment:BDP5290 is used as an anti-cancer agent for its ability to inhibit cancer invasion. By targeting both ROCK and MRCK, it can effectively block the invasiveness of cancer cells, potentially leading to improved outcomes for patients with various types of cancer.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, BDP5290 is used as a research compound for the development of new cancer therapies. Its dual inhibition of ROCK and MRCK makes it a valuable tool for studying the mechanisms of cancer invasion and identifying potential therapeutic targets.
Used in Drug Discovery:
BDP5290 is used as a lead compound in drug discovery efforts, as its unique mechanism of action may offer new avenues for the development of effective cancer treatments. Researchers can use BDP5290 as a starting point to design and optimize new drugs that target the ROCK and MRCK pathways, potentially leading to more effective and targeted cancer therapies.
Check Digit Verification of cas no
The CAS Registry Mumber 1817698-21-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,8,1,7,6,9 and 8 respectively; the second part has 2 digits, 2 and 1 respectively.Calculate Digit Verification of CAS Registry Number 1817698-21:
(9*1)+(8*8)+(7*1)+(6*7)+(5*6)+(4*9)+(3*8)+(2*2)+(1*1)=217
217 % 10 = 7
So 1817698-21-7 is a valid CAS Registry Number.
1817698-21-7Upstream product
1817698-21-7Downstream Products
Post a RFQ
1
What can I do for you?
Get Best Price
Get Best Price for 1817698-21-7
BDP5290
